Finance

Lists
Why is MREO down 6,74%?
Dive Deeper
MREO:NASDAQ
Mereo BioPharma Group plc - ADR
0,35 $
-6,74%
(-0,025) 1D
0,35 $
-0,06% (-0,00020)
After hours
Closed: 9 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MREO...
Open
0,38 $
High
0,39 $
Low
0,34 $
Mkt. cap
55,17 մլն
Avg. vol.
1,76 մլն
Volume
1,22 մլն
52-wk high
2,37 $
52-wk low
0,20 $
EPS
-0,18 $
Beta
0,14
Shares outstanding
159,69 մլն
No. of employees
39
Open
0,38 $
High
0,39 $
Low
0,34 $
Mkt. cap
55,17 մլն
Avg. vol.
1,76 մլն
Volume
1,22 մլն
52-wk high
2,37 $
52-wk low
0,20 $
EPS
-0,18 $
Beta
0,14
Shares outstanding
159,69 մլն
No. of employees
39
News stories
From web sources and news partners
About Mereo BioPharma Group plc - ADR
CEODenise Scots-Knight
Employees39
Founded2015
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to MREO in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MREO in the last 3 months.
Highest
Current 0,35 $
3,00 $ (+757,39%)
Average
3,00 $ (+757,39%)
Lowest
3,00 $ (+757,39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
3,00 $
+757,4%
09/17/2026
Priyanka Grover
J.P. Morgan
Sell
Reiterated
-
-
09/15/2026
Kate Dellorusso
LifeSci Capital
Hold
Maintained
-
-
08/15/2026
Gil Blum
Needham
Buy
Maintained
3,00 $
+757,4%
08/11/2026
Julian Harrison
BTIG
Buy
Maintained
1,00 $
+185,8%
03/19/2026
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,82 մլն
3,72 մլն
4,65 մլն
1,69 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,04 մլն
4,20 մլն
4,02 մլն
5,22 մլն
Operating expense
9,87 մլն
7,62 մլն
8,67 մլն
6,91 մլն
Total operating expenses
9,87 մլն
7,62 մլն
8,67 մլն
6,91 մլն
Operating income
-9,87 մլն
-7,62 մլն
-8,67 մլն
-6,91 մլն
Other non operating income
496,00 հզր
-6,00 հզր
17,00 հզր
6,00 հզր
EBT including unusual items
-7,02 մլն
-7,35 մլն
-6,72 մլն
-7,00 մլն
EBT excluding unusual items
-7,02 մլն
-7,35 մլն
-6,72 մլն
-7,00 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-300,00 հզր
-
-
Net income
-7,02 մլն
-7,35 մլն
-6,72 մլն
-7,00 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
504,00 հզր
421,00 հզր
327,00 հզր
278,00 հզր
Interest expense
-28,00 հզր
-23,00 հզր
-20,00 հզր
-16,00 հզր
Net interest expenses
476,00 հզր
398,00 հզր
307,00 հզր
262,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,82 մլն
-7,16 մլն
-8,50 մլն
-6,75 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps